Modulation of brain injury as a target of adjunctive therapy in bacterial meningitis

Current Infectious Disease Reports

Volumn 12, Issue 4, 2010, Pages 266-273

  Koedel, Uwe ^a,b   Klein, Matthias ^a   Pfister, Hans Walter ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Daptomycin; Dexamethasone; Rifampicin; Roscovitine; Streptococcus pneumoniae

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL TOXIN; BB 1101; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; CORTICOSTEROID; CYTOTOXIN; DAPTOMYCIN; ILOMASTAT; MATRIX METALLOPROTEINASE INHIBITOR; RIFAMPICIN; ROSCOVITINE; TNF 484; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ANTIMICROBIAL THERAPY; BACTERIAL MENINGITIS; BLOOD VESSEL INJURY; BRAIN INJURY; COCHLEA INJURY; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG TARGETING; EAR DISEASE; EXPERIMENTAL STUDY; HIPPOCAMPUS; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MORBIDITY; MORTALITY; NEUROLOGICAL COMPLICATION; NONHUMAN; OUTCOME ASSESSMENT; PNEUMOCOCCAL MENINGITIS; REVIEW;

EID: 77956263011     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-010-0116-1     Document Type: Review

References (48)

1. O Dzupova H Rozsypal B Prochazka, et al. 2009 Acute bacterial meningitis in adults: predictors of outcome Scand J Infect Dis 41 348 354 10.1080/00365540902849391 1:CAS:528:DC%2BD1MXnvVWqsrc%3D 19306157 This study demonstrates that acute bacterial meningitis remains associated with significant morbidity and mortality, even in the developed world
2. M Ramakrishnan AJ Ulland LC Steinhardt, et al. 2009 Sequelae due to bacterial meningitis among African children: a systematic literature review BMC Med 7 47 10.1186/1741-7015-7-47 19751516 This article gives a comprehensive review of data on sequelae of bacterial meningitis in children from the African continent. The highest in-hospital case fatality ratios observed were for pneumococcal meningitis (median = 35%) and Haemophilus influenzae type B (Hib) meningitis (median = 25%). Moreover, pneumococcal and HiB meningitis cause clinically evident sequelae in a quarter of survivors prior to hospital discharge
3. R Nau A Soto W Bruck 1999 Apoptosis of neurons in the dentate gyrus in humans suffering from bacterial meningitis J Neuropathol Exp Neurol 58 265 274 10.1097/00005072-199903000-00006 1:STN:280:DyaK1M3htFKktw%3D%3D 10197818
4. Koedel U, Klein M, Pfister HW: New understandings on the pathophysiology of bacterial meningitis. Curr Opin Infect Dis 2010, 23:217-223.
5. AM Assiri FA Alasmari VA Zimmerman, et al. 2009 Corticosteroid administration and outcome of adolescents and adults with acute bacterial meningitis: a meta-analysis Mayo Clin Proc 84 403 409 10.4065/84.5.403 1:CAS:528:DC%2BD1MXmtVWhtLg%3D 19411436 A systematic review and meta-analysis that was performed by searching several databases for reports (published from January 1966 through February 2008) of placebo-controlled randomized trials of corticosteroid use in the treatment of adolescents and adults with acute bacterial meningitis. The meta-analysis suggests that adjunctive corticosteroids are beneficial in the treatment of adolescents and adults with bacterial meningitis in patient populations similar to those seen in high-income countries and in areas with a low prevalence of HIV infection
6. SL Leib C Heimgartner YD Bifrare, et al. 2003 Dexamethasone aggravates hippocampal apoptosis and learning deficiency in pneumococcal meningitis in infant rats Pediatr Res 54 353 357 10.1203/01.PDR.0000079185.67878.72 1:CAS:528:DC%2BD3sXmtFGltrk%3D 12788989
7. ES Schut MC Brouwer J de Gans, et al. 2009 Delayed cerebral thrombosis after initial good recovery from pneumococcal meningitis Neurology 73 1988 1995 10.1212/WNL.0b013e3181c55d2e 1:STN:280:DC%2BD1MfhtFCjtA%3D%3D 19890068 This article is a report of six selected patients with stroke complicating pneumococcal meningitis, pointing at delayed stroke as a possible side effect of corticosteroid therapy in pneumococcal meningitis
8. J Gerber RC Seitz S Bunkowski, et al. 2009 Evidence for frequent focal and diffuse acute axonal injury in human bacterial meningitis Clin Neuropathol 28 33 39 1:STN:280:DC%2BD1M7jvF2gtw%3D%3D 19216218 This histopathologic study shows that axonal injury is a frequent complication of bacterial meningitis probably contributing to long-term sequelae in survivors
9. D van de Beek J De Gans L Spanjaard, et al. 2004 Clinical features and prognostic factors in adults with bacterial meningitis N Engl J Med 351 1849 1859 10.1056/NEJMoa040845 15509818
10. S Kastenbauer HW Pfister 2003 Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases Brain 126 1015 1025 10.1093/brain/awg113 12690042
11. J Katchanov E Siebert M Endres, et al. 2009 Focal parenchymal lesions in community-acquired bacterial meningitis in adults: a clinico-radiological study Neuroradiology 51 723 729 10.1007/s00234-009-0565-0 19618175 This neuroradiological study implied that parenchymal lesions in acute bacterial meningitis are mainly ischemic and due to involvement of large-, medium-, and small-sized arteries of the brain
12. JS Braun R Novak K-H Herzog, et al. 1999 Neuroprotection by a caspase inhibitor in acute bacterial meningitis Nat Med 5 298 302 10.1038/6514 1:CAS:528:DyaK1MXhsVSlt7w%3D 10086385
13. SL Leib D Leppert J Clements, et al. 2000 Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis Infect Immun 68 615 620 10.1128/IAI.68.2.615-620.2000 1:CAS:528:DC%2BD3cXotFOmsQ%3D%3D 10639424
14. D Grandgirard O Steiner MG Tauber, et al. 2007 An infant mouse model of brain damage in pneumococcal meningitis Acta Neuropathol 114 609 617 10.1007/s00401-007-0304-8 17938941
15. M Klein R Paul B Angele, et al. 2006 Protein expression pattern in experimental pneumococcal meningitis Microbes Infect 8 974 983 10.1016/j.micinf.2005.10.013 1:CAS:528:DC%2BD28XktVGgtLw%3D 16488173
16. O Hoffmann J Priller T Prozorovski, et al. 2007 TRAIL limits excessive host immune responses in bacterial meningitis J Clin Invest 117 2004 2013 10.1172/JCI30356 1:CAS:528:DC%2BD2sXnvVansbY%3D 17571163
17. C Ostergaard C Brandt HB Konradsen, et al. 2004 Differences in survival, brain damage, and cerebrospinal fluid cytokine kinetics due to meningitis caused by 3 different Streptococcus pneumoniae serotypes: evaluation in humans and in 2 experimental models J Infect Dis 190 1212 1220 10.1086/423852 15346330
18. JR Weber EI Tuomanen 2007 Cellular damage in bacterial meningitis: an interplay of bacterial and host driven toxicity J Neuroimmunol 184 45 52 10.1016/j.jneuroim.2006.11.016 1:CAS:528:DC%2BD2sXislejtLw%3D 17210186
19. O Schneider U Michel G Zysk, et al. 1999 Clinical outcome in pneumococcal meningitis correlates with CSF lipoteichoic acid concentrations Neurology 53 1584 1587 1:STN:280:DC%2BD3c%2FgtFynsw%3D%3D 10534274
20. U Koedel 2009 Toll-like receptors in bacterial meningitis Curr Top Microbiol Immunol 336 15 40 10.1007/978-3-642-00549-7-2 1:CAS:528: DC%2BC3cXisVamtr8%3D 19688326
21. B Opitz A Puschel B Schmeck, et al. 2004 Nucleotide-binding oligomerization domain proteins are innate immune receptors for internalized Streptococcus pneumoniae J Biol Chem 279 36426 36432 10.1074/jbc.M403861200 1:CAS:528:DC%2BD2cXmvFCnurk%3D 15215247
22. X Liu VS Chauhan AB Young 2010 Marriott I: NOD2 mediates inflammatory responses of primary murine glia to Streptococcus pneumoniae Glia 58 839 847 20091781 This experimental study showed that the cytosolic pattern recognition receptor NOD2 is required for the elevated inflammatory mediator levels, astrogliosis, and demyelination, following in vivo intracerebral administration of S. pneumoniae, suggesting that NOD2 plays a critical role in the establishment of the lethal inflammation associated with meningitis
23. M Klein B Angele HW Pfister, et al. 2008 Detection of pneumococcal infection of the central nervous system depends upon TLR2 and TLR4 J Infect Dis 198 1028 1036 10.1086/591626 1:CAS:528:DC%2BD1cXhtF2rtbfF 18700834
24. U Koedel T Rupprecht B Angele, et al. 2004 MyD88 is required for mounting a robust host immune response to Streptococcus pneumoniae in the CNS Brain 127 1437 1445 10.1093/brain/awh171 15115715
25. PJ Zwijnenburg T Van der Poll S Florquin, et al. 2003 IL-1 receptor type 1 gene-deficient mice demonstrate an impaired host defense against pneumococcal meningitis J Immunol 170 4724 4730 1:CAS:528:DC%2BD3sXjtVKnt7Y%3D 12707352
26. PJ Zwijnenburg T Van der Poll S Florquin, et al. 2003 Interleukin-18 gene-deficient mice show enhanced defense and reduced inflammation during pneumococcal meningitis J Neuroimmunol 138 31 37 10.1016/S0165-5728(03)00088-2 1:CAS:528:DC%2BD3sXjs1agtLc%3D 12742650
27. D Bogaert CM Thompson K Trzcinski, et al. 2010 The role of complement in innate and adaptive immunity to pneumococcal colonization and sepsis in a murine model Vaccine 28 681 685 10.1016/j.vaccine.2009.10.085 1:CAS:528: DC%2BD1MXhsFaiu77I 19892042
28. TA Rupprecht B Angele M Klein, et al. 2007 Complement C1q and C3 are critical for the innate immune response to Streptococcus pneumoniae in the central nervous system J Immunol 178 1861 1869 1:CAS:528:DC%2BD2sXntVGktw%3D%3D 17237437
29. EI Tuomanen K Saukkonen S Sande, et al. 1989 Reduction of inflammation, tissue damage, and mortality in bacterial meningitis in rabbits treated with monoclonal antibodies against adhesion-promoting receptors of leukocytes J Exp Med 170 959 969 10.1084/jem.170.3.959 1:STN:280:DyaL1MzmtFalsw%3D%3D 2570120
30. U Koedel T Frankenberg S Kirschnek, et al. 2009 Apoptosis is essential for neutrophil functional shutdown and determines tissue damage in experimental pneumococcal meningitis PLoS Pathog 5 e1000461 10.1371/journal.ppat.1000461 19478887 This study indicates that apoptosis is essential to turn off activated neutrophils and shows that inflammatory activity and disease severity in pneumococcal meningitis can be modulated by targeting the apoptotic pathway in neutrophils
31. PM Small MG Tauber CJ Hackbarth, et al. 1986 Influence of body temperature on bacterial growth rates in experimental pneumococcal meningitis in rabbits Infect Immun 52 484 487 1:STN:280:DyaL287psVOhuw%3D%3D 3699893
32. M Klein U Koedel HW Pfister 2006 Oxidative stress in pneumococcal meningitis: a future target for adjunctive therapy? Prog Neurobiol 80 269 280 10.1016/j.pneurobio.2006.11.008 1:CAS:528:DC%2BD2sXntlyhsA%3D%3D 17215069
33. S Kastenbauer U Koedel BF Becker, et al. 2002 Oxidative stress in bacterial meningitis in humans Neurology 58 186 191 1:CAS:528: DC%2BD38XhtVyks7Y%3D 11805243
34. D Leppert RL Lindberg L Kappos, et al. 2001 Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis Brain Res Brain Res Rev 36 249 257 10.1016/S0165-0173(01)00101-1 1:CAS:528:DC%2BD3MXnvFCkt7k%3D 11690622
35. DN Meli JM Loeffler P Baumann, et al. 2004 In pneumococcal meningitis a novel water-soluble inhibitor of matrix metalloproteinases and TNF-α converting enzyme attenuates seizures and injury of the cerebral cortex J Neuroimmunol 151 6 11 10.1016/j.jneuroim.2004.01.026 1:CAS:528: DC%2BD2cXktVOmsLg%3D 15145598
36. J Hu PE Van den Steen QX Sang, et al. 2007 Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases Nat Rev Drug Discov 6 480 498 10.1038/nrd2308 1:CAS:528:DC%2BD2sXmtVSmtbk%3D 17541420
37. G Zysk BK Schneider-Wald JH Hwang, et al. 2001 Pneumolysin is the main inducer of cytotoxicity to brain microvascular endothelial cells caused by Streptococcus pneumoniae Infect Immun 69 845 852 10.1128/IAI.69.2.845-852.2001 1:CAS:528:DC%2BD3MXns1SqsA%3D%3D 11159977
38. 2 mediate brain cell apoptosis during meningitis J Clin Invest 109 19 27 1:CAS:528:DC%2BD38XjtlaksQ%3D%3D 11781347
39. RA Hirst B Gosai A Rutman, et al. 2003 Streptococcus pneumoniae damages the ciliated ependyma of the brain during meningitis Infect Immun 71 6095 6100 10.1128/IAI.71.10.6095-6100.2003 1:CAS:528:DC%2BD3sXnslyksrY%3D 14500537
40. RA Hirst B Gosai A Rutman, et al. 2008 Streptococcus pneumoniae deficient in pneumolysin or autolysin has reduced virulence in meningitis J Infect Dis 197 744 751 10.1086/527322 18260758 In an adult rat model, pneumolysin and autolysin were demonstrated to play crucial roles in brain tissue injury in experimental pneumococcal meningitis
41. P Cottagnoud M Pfister F Acosta, et al. 2004 Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis Antimicrob Agents Chemother 48 3928 3933 10.1128/AAC.48.10.3928-3933.2004 1:CAS:528:DC%2BD2cXosVygsbk%3D 15388454
42. D Grandgirard C Schurch P Cottagnoud, et al. 2007 Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis Antimicrob Agents Chemother 51 2173 2178 10.1128/AAC.01014-06 1:CAS:528:DC%2BD2sXmtlKrsbo%3D 17371820 In an infant rat model of pneumococcal meningitis, daptomycin was shown to be protective against the development of cortical brain injury
43. D Grandgirard K Oberson A Buhlmann, et al. 2010 Attenuation of cerebrospinal fluid inflammation by the non-bacteriolytic antibiotic daptomycin vs ceftriaxone in experimental pneumococcal meningitis Antimicrob Agents Chemother 54 1323 1326 10.1128/AAC.00812-09 1:CAS:528:DC%2BC3cXjtFWqt74%3D 20065062
44. T Bottcher J Gerber A Wellmer, et al. 2000 Rifampin reduces production of reactive oxygen species of cerebrospinal fluid phagocytes and hippocampal neuronal apoptosis in experimental Streptococcus pneumoniae meningitis J Infect Dis 181 2095 2098 10.1086/315518 1:CAS:528:DC%2BD3cXltVClsrk%3D 10837202
45. R Nau A Wellmer A Soto, et al. 1999 Rifampin reduces early mortality in experimental Streptococcus pneumoniae meningitis J Infect Dis 179 1557 1560 10.1086/314760 1:CAS:528:DyaK1MXjvFelt7c%3D 10228082
46. A Spreer R Lugert V Stoltefaut, et al. 2009 Short-term rifampicin pretreatment reduces inflammation and neuronal cell death in a rabbit model of bacterial meningitis Crit Care Med 37 2253 2258 10.1097/CCM.0b013e3181a036c0 1:CAS:528:DC%2BD1MXnsFyisrw%3D 19487938 The authors reported that a short-term pretreatment with rifampicin reduced the β-lactam-induced release of deleterious bacterial products and thereby decreased neuronal cell loss in an adult rabbit model of experimental pneumococcal meningitis
47. Grandgirard D, Burri M, Oberson K, et al.: In infant rat pneumococcal meningitis, ceftriaxone plus daptomycin versus ceftriaxone attenuates brain damage and hearing loss while ceftriaxone plus rifampicin does not [abstract O381]. Presented at ECCMID 2009. Helsinki, Finland; May 16-19, 2010.
48. AG Rossi DA Sawatzky A Walker, et al. 2006 Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis Nat Med 12 1056 1064 10.1038/nm1468 1:CAS:528:DC%2BD28XptFClur8%3D 16951685